EDITEditas Medicine, Inc.
$2.83-28% 1Y
$2.83
$1.6652 weeks$4.15
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Choppy, but holding above its 200-day average. Price is +7% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How EDIT is trading
Editas Medicine, Inc. is −28% over the past year while the S&P 500 is +18%: 46 points behind the market.
−28%
1-year return · S&P 500 +18%
- vs 200-day average
- +7.0%
vs 200-day average · close to trend
- RSI (14)
- 55
RSI (14) · neutral
- Below its 52-week high
- 32%
Below its 52-week high
Details›
- Last close2026-10-08
- $2.83
- 1 monthS&P 500 +1.6%
- +1.8%
- 1 yearS&P 500 +18%
- −28%
- 5 yearsS&P 500 +86%
- −93%
- vs 50-day average$2.84
- −0.49%
- 52-week high
- $4.15
- 52-week low
- $1.66
- Annualised volatility
- 114%
| Year | Return |
|---|---|
| 2026 (year to date) | +38% |
| 2025 | +61% |
| 2024 | −87% |
| 2023 | +14% |
| 2022 | −67% |
| 2021 | −62% |
| 2020 | +137% |
| 2019 | +30% |
| 2018 | −26% |
| 2017 | +89% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −4.9% |
| Feb | 10 | 5 of 10 | +7.5% |
| Mar | 10 | 3 of 10 | −7.9% |
| Apr | 10 | 5 of 10 | +0.12% |
| May | 10 | 5 of 10 | +0.43% |
| Jun | 10 | 6 of 10 | +12% |
| Jul | 11 | 7 of 11 | +1.4% |
| Aug | 11 | 7 of 11 | +5.0% |
| Sep | 11 | 2 of 11 | −8.4% |
| Oct | 11 | 5 of 11 | −4.4% |
| Nov | 10 | 5 of 10 | +7.1% |
| Dec | 10 | 3 of 10 | +2.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.